RAPS.org
|
About RAPS
|
RAPS Store
|
Contact
Guest
| limited access
log in
Join RAPS
Get the Mobile App
|
RF in Your Email
News
Features
Archives
About RF
Advertise
Regulatory Exchange
Departments:
Under RAPS
Quality & Compliance
Science & Technology
Perspective
It's the Law
Focus Online
»
News
»
News - Article View
News
Search:
Latest News
|
10 August 2012
Orphan Drug Marketing Exclusivity Revoked from Product as FDA Admits Error
0 Likes
In a groundbreaking move, the US Food and Drug Administration (FDA) moved to rescind marketing exclusivity for an orphan drug product manufactured by OctaPharma used for the treatment of von
Read More...
Tags:
CSL Behring
FDA
FVIII
Humate
Marketing Exclusivity
Octapharma
Orphan Drug
Revoked
Wilate
Get
RF Today
RF Today
is
Regulatory Focus'
daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more.
Learn more
Sign Up
Related News